Sign Up to like & get
recommendations!
0
Published in 2021 at "European Journal of Neurology"
DOI: 10.1111/ene.14948
Abstract: Preparations for clinical trials of unfolded protein response (UPR) inhibitors (such as Sephin1) that target the upregulated UPR in patients with Charcot–Marie–Tooth disease (CMT) carrying MPZ mutations are currently underway. The inclusion criteria for these…
read more here.
Keywords:
genotype phenotype;
phenotype correlation;
myelin protein;
french patients ... See more keywords